Potentially malignant oral lesions are visible mucosal changes with risk of progressing to squamous cell carcinoma. These lesions are currently graded as no, mild, moderate, or severe dysplasia per WHO guidelines. While widely used,…
Continue Reading
Introduction to CHIME’s Digital Health Recognition
The College of Healthcare Information Management Executives has unveiled its prestigious 2025 Digital Health Most Wired survey results, recognizing 18 exceptional hospitals and health systems with the coveted Level…
What You Should Know:
– Labcorp, a global leader in laboratory services, has announced a collaboration with Roche to implement the company’s FDA-cleared VENTANA® DP 600 and DP 200 slide scanners.
– The investment is a…
Continue Reading
What You Should Know:
– Proscia, a pathology AI company, has announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data…
Continue Reading
Steve Blunden, Peninsula Pathology digital pathology lead (first on right), alongside Peninsula Pathology Network and University Hospitals Plymouth NHS Trust teams (Credit: University Hospitals Plymouth NHS Trust)
Five NHS sites in Devon and Cornwall…
Continue Reading
Kevin Coady, Business Leader for Disease Management Solutions & Digital Pathology at Philips North America
Understanding Prostate Cancer: Not All Are the Same
Prostate cancer is the second most common cancer in men, but what many…
Continue Reading
Krishna Subramanian, COO & Co-Founder at Komprise
Healthcare organizations are experiencing a seismic shift in how they handle unstructured data. From digital pathology to high-resolution imaging, genomic sequencing, and machine-generated sensor data, the volume of…
Continue Reading
What You Should Know:
– Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
– The acquisition, valued at $81.25M, paid predominantly…
Continue Reading
What You Should Know:
– PathAI, a provider of AI and digital pathology solutions, and Moffitt Cancer Center, a top cancer hospital, have announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight®…
Continue Reading
We developed a rapid scanning optical microscope, termed “BlurryScope”, that leverages continuous image acquisition and deep learning to provide a cost-effective and compact solution for automated inspection and analysis of tissue sections. This device…
Continue Reading
